TET2 and neoplasm: Interestingly, in melanoma Tet2‐mutant CHIP effects seem to act contrary, resulting in reduced tumor burden via a Tet2‐loss mediated onset of proinflammatory tumor‐associated macrophage phenotype that promotes T‐cell infiltration [49].